Literature DB >> 31655168

Sepsis roadmap: What we know, what we learned, and where we are going.

Vijay Kumar1.   

Abstract

Sepsis is a life-threatening condition originating as a result of systemic blood infection causing, one or more organ damage due to the dysregulation of the immune response. In 2017, the world health organization (WHO) declared sepsis as a disease of global health priority, needing special attention due to its high prevalence and mortality around the world. Most of the therapeutics targeting sepsis have failed in the clinics. The present review highlights the history of the sepsis, its immunopathogenesis, and lessons learned after the failure of previously used immune-based therapies. The subsequent section, where to go describes in details the importance of the complement system (CS), autophagy, inflammasomes, and microbiota along with their targeting to manage sepsis. These systems are interconnected to each other, thus targeting one may affect the other. We are in an urgent need for a multi-targeting therapeutic approach for sepsis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Complement system; Immune system; Inflammasomes; Microbiota; Sepsis

Year:  2019        PMID: 31655168     DOI: 10.1016/j.clim.2019.108264

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  Age-Dependent Microglial Response to Systemic Infection.

Authors:  Brianna Cyr; Juan Pablo de Rivero Vaccari
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

2.  Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis.

Authors:  Xijie Dong; Chuntao Wang; Xinghua Liu; Wei Gao; Xiangjun Bai; Zhanfei Li
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

Review 3.  The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA.

Authors:  Vijay Kumar
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

Review 4.  Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine.

Authors:  Luca Cioccari; Nora Luethi; Mojgan Masoodi
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

Review 5.  Resveratrol: Potential Application in Sepsis.

Authors:  Jiajia Li; Xiaoting Zeng; Fuxun Yang; Lan Wang; Xiaoxiu Luo; Rongan Liu; Fan Zeng; Sen Lu; Xiaobo Huang; Yu Lei; Yunping Lan
Journal:  Front Pharmacol       Date:  2022-02-09       Impact factor: 5.810

6.  Circulating mitochondrial DNA-triggered autophagy dysfunction via STING underlies sepsis-related acute lung injury.

Authors:  Qinjie Liu; Jie Wu; Xufei Zhang; Xuanheng Li; Xiuwen Wu; Yun Zhao; Jianan Ren
Journal:  Cell Death Dis       Date:  2021-07-03       Impact factor: 8.469

7.  Macrophage-Derived MicroRNA-21 Drives Overwhelming Glycolytic and Inflammatory Response during Sepsis via Repression of the PGE2/IL-10 Axis.

Authors:  Paulo De Melo; Annie Rocio Pineros Alvarez; Xiang Ye; Amondrea Blackman; Jose Carlos Alves-Filho; Alexandra I Medeiros; Jeffrey Rathmell; Heather Pua; C Henrique Serezani
Journal:  J Immunol       Date:  2021-07-23       Impact factor: 5.426

Review 8.  Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.

Authors:  Huan Lin; Wenting Wang; Madeline Lee; Qinghe Meng; Hongsheng Ren
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

Review 9.  Autophagy Regulation on Pyroptosis: Mechanism and Medical Implication in Sepsis.

Authors:  Ran Guo; Hao Wang; Na Cui
Journal:  Mediators Inflamm       Date:  2021-06-24       Impact factor: 4.711

10.  Vitamin C, Hydrocortisone, and the Combination Thereof Significantly Inhibited Two of Nine Inflammatory Markers Induced by Escherichia Coli But Not by Staphylococcus Aureus - When Incubated in Human Whole Blood.

Authors:  Pedro Miguel Coelho Medeiros; Camilla Schjalm; Dorte Christiansen; Marina Sokolova; Soeren Erik Pischke; Reinhard Würzner; Tom Eirik Mollnes; Andreas Barratt-Due
Journal:  Shock       Date:  2022-01-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.